Firebrick Pharma Ltd
ASX:FRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Anhui Jianghuai Automobile Group Corp Ltd
SSE:600418
|
CN |
Firebrick Pharma Ltd
Total Current Liabilities
Firebrick Pharma Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Firebrick Pharma Ltd
ASX:FRE
|
Total Current Liabilities
AU$271.3k
|
CAGR 3-Years
-16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Total Current Liabilities
AU$11.4m
|
CAGR 3-Years
114%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Total Current Liabilities
AU$261m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Total Current Liabilities
AU$4.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
42%
|
CAGR 10-Years
6%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Total Current Liabilities
AU$10.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Total Current Liabilities
AU$545.6k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Firebrick Pharma Ltd
Glance View
Firebrick Pharma Ltd. engages in the development and manufacture of pharmaceutical products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2022-01-28. The firm is focused to develop Nasodine, a nasal spray that contains the broad spectrum antimicrobial agent called povidone-iodine. The firm is engaged in product formulation, packaging and manufacturing development. Nasodine nasal spray medicine targets the cause of colds, where they start in the nose. Its nasal spray is responsible for respiratory infections, such as the common cold. The firm's Series C funding, Phase III trial has been completed.
See Also
What is Firebrick Pharma Ltd's Total Current Liabilities?
Total Current Liabilities
271.3k
AUD
Based on the financial report for Jun 30, 2025, Firebrick Pharma Ltd's Total Current Liabilities amounts to 271.3k AUD.
What is Firebrick Pharma Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
5%
Over the last year, the Total Current Liabilities growth was -7%. The average annual Total Current Liabilities growth rates for Firebrick Pharma Ltd have been -16% over the past three years , 5% over the past five years .
